• Elisa Menozzi, Jane Macnaughtan, and SchapiraAnthony H VAHVDepartment of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, London, UK..
• Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, London, UK.
• Ann. Med. 2021 Dec 1; 53 (1): 611625611-625.

AbstractGastrointestinal disorders are one of the most significant non-motor problems affecting people with Parkinson disease (PD). Pathogenetically, the gastrointestinal tract has been proposed to be the initial site of pathological changes in PD. Intestinal inflammation and alterations in the gut microbiota may contribute to initiation and progression of pathology in PD. However, the mechanisms underlying this "gut-brain" axis in PD remain unclear. PD patients can display a large variety of gastrointestinal symptoms, leading to reduced quality of life and psychological distress. Gastrointestinal disorders can also limit patients' response to medications, and consequently negatively impact on neurological outcomes. Despite an increasing research focus, gastrointestinal disorders in PD remain poorly understood and their clinical management often suboptimal. This review summarises our understanding of the relevance of the "gut-brain" axis to the pathogenesis of PD, discusses the impact of gastrointestinal disorders in patients with PD, and provides clinicians with practical guidance to their management.

18 keywords...

hide…